Table 2. Multivariate logistic regression analysis of detecting independent factors for high GS ( > 47-point).
Variables | Model 1 |
Model 2 |
|||||
OR | 95% CI | P value | OR | 95% CI | P-value | ||
LDL-C | 1.01 | 1.00–1.02 | 0.004 | 1.01 | 1.00–1.02 | 0.048 | |
Non-HDL-C | 8.40 | 1.51–46.8 | 0.014 | 5.42 | 0.57–51.59 | 0.142 | |
ApoB | 1.01 | 1.00–1.02 | 0.002 | 1.01 | 1.00–1.02 | 0.091 | |
Lipoprotein (A) | 2.06 | 1.23–3.47 | 0.006 | 1.65 | 1.04–3.03 | 0.045 | |
TC/HDL-C | 1.32 | 1.08–1.62 | 0.008 | 1.42 | 0.72–2.80 | 0.310 | |
LDL-C/HDL-C | 1.57 | 1.19–2.06 | 0.001 | 1.43 | 1.03–1.98 | 0.033 | |
ApoB/HDL-C | 1.62 | 1.21–2.15 | 0.001 | 1.36 | 0.98–1.91 | 0.069 | |
Non-HDL-C/ApoA-1 | 3.35 | 1.49–7.51 | 0.003 | 3.42 | 1.21–9.67 | 0.021 | |
LDL-C/ApoA-1 | 5.41 | 1.98–14.81 | 0.001 | 4.65 | 1.35–15.97 | 0.015 | |
ApoB/ApoA-1 | 10.33 | 3.04–35.14 | 0.000 | 5.67 | 1.45–23.92 | 0.018 |
Abnormal distribution data were analyzed after logarithmic transforming. Model 1: adjusted for gender, age, current smoking, hypertension, hyperlipidemia, family history of CAD; Model 2: as in model 1 further adjusted for LVEF, HbA1C, duration of diabetes, and statin therapy (before hospitalization). ApoA-1: apolipoprotein A-1; ApoB: apolipoprotein B; CAD: coronary artery disease; GS: Gensini score; HbA1C: glycosylated hemoglobinA1C; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; TC: total cholesterol.